How much funding has PhenoVista BioSciences raised?

PhenoVista BioSciences has disclosed $3M raised across 1 round.

Where is PhenoVista BioSciences headquartered?

PhenoVista BioSciences is headquartered in San Diego, US.

PhenoVista BioSciences

San Diego, US · Founded 2022 · Delaware corporation

Find your way into PhenoVista BioSciences

Paths you didn't know you had: your email and LinkedIn already hold routes to the PhenoVista BioSciences team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

PhenoVista provides contract research services focused on phenotypic and high-content imaging studies, using quantitative fluorescence microscopy and cell-based disease models to support R&D and drug discovery decisions. It serves life science and biotech researchers.

Biotech Deep Tech Healthtech

Founders & leadership

James G. Evans, Ph.D.CEO

Anthony Essex, Ph.D.CSO

Brian ConnNamed on SEC filing

James G. EvansCEO

Anthony EssexNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$3M disclosed across 1 round · 2022

▶$3MraisedJan 2023 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Brian ConnExecutive Officer
James G. EvansExecutive Officer, Director
Anthony EssexExecutive Officer, Director

Offering amount: $3M
Amount sold: $3M
Minimum investment: $3M
First sale: Dec 2022
Incorporated: Corporation, Delaware, 2022
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

Emulate BioEmulate builds Organ-on-a-Chip systems, including platforms, consumables, and pre-assembled BioKits with validated human cell models, to support drug discovery research. It serves life sciences and pharmaceutical researchers and provides installation, training, and validated protocols for Organ-Chip experiments.

InVivo BiosystemsBiotechnology company providing solutions for genetic research and drug discovery.

Companies working in the same space as PhenoVista BioSciences.

Non-dilutive funding · 3 SBIR/STTR awards

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Institutes of Health (NIH)National Institutes of Health	Phase I	2021	$249.9K
National Institutes of Health (NIH)National Institutes of Health	Phase II	2020	$1.4M
National Institutes of Health (NIH)National Institutes of Health	Phase I	2017	$149.8K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does PhenoVista BioSciences do?: PhenoVista provides contract research services focused on phenotypic and high-content imaging studies, using quantitative fluorescence microscopy and cell-based disease models to support R&D and drug discovery decisions. It serves life science and biotech researchers.
How much funding has PhenoVista BioSciences raised?: PhenoVista BioSciences has disclosed $3M raised across 1 round.
Where is PhenoVista BioSciences headquartered?: PhenoVista BioSciences is headquartered in San Diego, US.